Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 2
2002 1
2003 2
2005 3
2006 3
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.
Fernández S, Año G, Castaño J, Pino Y, Uribarri E, Riverón LA, Cedré B, Valmaseda T, Falero G, Pérez JL, Infante JF, García LG, Solís RL, Sierra G, Talavera A. Fernández S, et al. Among authors: valmaseda t. Travel Med Infect Dis. 2013 Mar-Apr;11(2):103-9. doi: 10.1016/j.tmaid.2012.10.006. Epub 2013 Mar 13. Travel Med Infect Dis. 2013. PMID: 23492079
Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A, Año G, Pino Y, Castaño J, Uribarri E, Riverón L, Gil S, Fernández S, Cedré B, Valmaseda T, Pérez JL, Infante JF, García L, Sierra G. Talavera A, et al. Among authors: valmaseda t. Vaccine. 2006 Apr 12;24(16):3381-7. doi: 10.1016/j.vaccine.2005.12.064. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16460846
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L, Jidy MD, García H, Rodríguez BL, Fernández R, Año G, Cedré B, Valmaseda T, Suzarte E, Ramírez M, Pino Y, Campos J, Menéndez J, Valera R, González D, González I, Pérez O, Serrano T, Lastre M, Miralles F, Del Campo J, Maestre JL, Pérez JL, Talavera A, Pérez A, Marrero K, Ledón T, Fando R. García L, et al. Among authors: valmaseda t. Infect Immun. 2005 May;73(5):3018-24. doi: 10.1128/IAI.73.5.3018-3024.2005. Infect Immun. 2005. PMID: 15845509 Free PMC article. Clinical Trial.
Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.
Benítez JA, García L, Silva A, García H, Fando R, Cedré B, Pérez A, Campos J, Rodríguez BL, Pérez JL, Valmaseda T, Pérez O, Pérez A, Ramírez M, Ledón T, Jidy MD, Lastre M, Bravo L, Sierra G. Benítez JA, et al. Among authors: valmaseda t. Infect Immun. 1999 Feb;67(2):539-45. doi: 10.1128/IAI.67.2.539-545.1999. Infect Immun. 1999. PMID: 9916056 Free PMC article. Clinical Trial.
Construction and characterisation of O139 cholera vaccine candidates.
Ledón T, Valle E, Valmaseda T, Cedré B, Campos J, Rodríguez BL, Marrero K, García H, García L, Fando R. Ledón T, et al. Among authors: valmaseda t. Vaccine. 2003 Mar 7;21(11-12):1282-91. doi: 10.1016/s0264-410x(02)00412-7. Vaccine. 2003. PMID: 12559810
13 results